会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • Finger deployed device for measuring blood and physiological characteristics
    • 用手指用于测量血和生理特征的装置
    • EP2181650A2
    • 2010-05-05
    • EP09174453.2
    • 2009-10-29
    • Cnoga Medical Ltd.
    • Segman, Yosef
    • A61B5/1455A61B5/1495A61B5/024
    • A61B5/0205A61B5/021A61B5/02427A61B5/14532A61B5/14539A61B5/14546A61B5/14552A61B5/1495A61B5/6826A61B5/6838A61B2560/0223
    • The present invention relates to a device for measuring blood and physiological characteristics by passing light through human tissue that is configured for deployment on a human finger. The device includes a lower finger-trough configured in the main housing of the device; a hingedly attached closeable lid that has an upper finger-trough configured for deployment of at least one finger stabilizing element, the lid being latchable in a closed position; a finger stabilizing element made of a material having flexibly soft malleable characteristics so as to sealingly engage the top of the finger; a light source that is deployed in the sloped end wall of the lower finger-trough adjacent to the lower portion of the finger tip; and an end cap the is deployable on the open end of the device when the lid is in the closed position, which enables calibration of the device with a minimum of light wave "noise" from ambient light.
    • 本发明涉及一种设备,用于通过光透人体组织并配置成用于对人的手指的部署测量血和生理特征。 该装置包括在下手指槽在该装置的主壳体配置; 一个铰链连接闭盖没有被配置用于至少一个手指稳定化元件的部署上手指槽,盖子被在闭合位置可锁定; 由具有弹性可延展的软特性的材料,以密封地接合手指的顶部的手指稳定化元件; 光源也可部署在在下手指槽毗邻手指尖的下部分的倾斜端壁; 和在端盖上的装置的开口端可展开当盖是在关闭位置,这使该装置的校准与来自环境光的最小光波“噪音”的。
    • 5. 发明公开
    • SYSTEM AND METHOD FOR CONTROLLING BLOOD GLUCOSE USING PERSONALIZED HISTOGRAMS
    • EP3603509A1
    • 2020-02-05
    • EP19188731.4
    • 2019-07-28
    • Cnoga Medical Ltd.
    • SEGMAN, Yosef
    • A61B5/145
    • A method of control of diabetes in a patient, comprising: measuring, using a non-invasive or invasive glucose measuring device, momentary glucose levels of the patient at multiple times a day during an initial time period either continuously or at discrete times, the initial time period being at least a week; recording the momentary glucose levels in a memory in communication with the device, the recording including optional information associated with a recent temporal glucose reading wherein the optional information including one or more of the following information: date, time, time of recent food eating, recent physical activity, diabetes treatment, body temperature, blood pressure, pulse, and drugs associated with the recent temporal glucose reading; constructing, using one or more processors in communication with the device, current curvilinear probability density functions of occurrences of the momentary glucose levels throughout the initial time period and displaying the curvilinear probability density functions on a screen; determining, using one or more processors, a quantitative assessment of at least one of the following current momentary markers during the measurement period from the momentary glucose levels recorded and the optional information: (i) Insulin Resistance (IR), (ii) Glucose Variability (GV), (iii) Glucose Severity Index (GSI) or (iv) Glucose Burden (GB), and constructing, using the one or more processors, a personalized target curvilinear probability density function for the patient based on the current curvilinear probability density functions.